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Introduction
Reactive oxygen species (ROS) such as superoxide, hydroxyl
and peroxyl radicals, and hydrogen peroxide (H2O2) are more
reactive than molecular oxygen (Thannickal and Fanburg,
2000) and therefore can indiscriminately oxidize biological
molecules, providing a constant threat to cells in an oxygen-
rich environment (Storz and Imlay, 1999). In living cells,
endogenous ROS are generated as byproducts of cellular
metabolism and through leakage of electrons from the
mitochondrial electron transport chain (Nohle et al., 2003);
they are also derived from exogenous sources such as UV
radiation, -irradiation and chemicals. Present in all aerobic
cells, ROS exist in a physiological balance with biochemical
antioxidants. Oxidative stress occurs when this critical balance
is disrupted, increasing intracellular ROS levels. To maintain
intracellular redox homeostasis and protect against oxidative
damage, cells have developed a sophisticated antioxidant
defense system by enlisting functional antioxidant buffers
through redox-coupled enzymatic networks that regenerate
oxidized substrates (Martindale and Holbrook, 2002; Waris
and Ahsan, 2006). In this system, superoxide dismutase (SOD)
converts the superoxide anion radical (O2–) to H2O2, which is
subsequently eliminated by catalase (CAT), glutathione
peroxidase 1 (Gpx1) and peroxiredoxin (Prx). Gpx1 – a
selenoprotein – is considered the primary enzyme responsible
for the removal of H2O2 and may have a role in the regulation
of cellular redox status (Burdon, 1995; de Hann et al., 1998).
Likewise, Prx is a major reductant of endogenously produced
peroxides in eukaryotes and catalyzes the conversion of H2O2
into H2O by using reducing equivalents provided by
thioredoxin (Trx) (Rhee et al., 2001; Chae et al., 1994a; Chae
et al., 1994b). During the peroxiredoxin catalytic cycle,
peroxidatic cysteine is oxidized to a sulfenic acid form, which
typically reacts with a proximal thiol to form a disulfide bond
(Georgiou and Masip, 2003; Woo et al., 2003). This
intermolecular disulfide bond is subsequently reduced by Trx;
however, because the formation of the resolving disulfide bond
is slow, high concentrations of ROS cause further oxidation of
the peroxidatic cysteine to sulfinic acid, yielding an inactive
form of Prx that cannot be reduced by typical cellular
reductants such as glutathione or thioredoxin (Rabilloud et al.,
2002; Wood et al., 2003; Yang et al., 2002). Sestrins are a
family of cysteine sulfinyl reductases and are essential for
reactivating Prx by reducing the cysteine sulfinic acid to thiol,
thus reestablishing the antioxidant firewall (Budanov et al.,
2004).
The tumor suppressor protein p53 is an important sensor of
cellular stress and is involved in regulating cellular responses
to DNA damage. Depending on the cell type and the context
of stimuli, p53 can either induce cell growth arrest to allow
repair or alternatively triggers apoptosis to prevent DNA
damage in abnormal or stress-exposed cells from becoming
fixed as a mutation (Lane, 1992). Additional evidence exists
suggesting that p53 works in a more positive way, participating
in the maintenance of intracellular redox homeostasis and
protection of the genome from oxidative damage. First, there
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HPV-positive cervical cancer cell lines. We found that SiHa
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cell lines. Downregulation of p53 resulted in the inhibition
of p53-regulated antioxidant enzymes and elevated
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are several p53-regulated genes such as GPX1, SOD2 and
aldehyde dehydrogenase 4 family member A1 (ALDH4A1),
which encode products that act as antioxidants (Hussain et al.,
2004; Tan et al., 1999; Yoon et al., 2004). Second, reactivation
of overoxidized Prx is mediated by two p53-regulated sestrins,
namely, PA26 and Hi95 (encoded by SESN1 and SESN2,
respectively), which are required for regeneration of Prx
containing cysteine sulfinic acid. Third, in the absence of stress
or after mild stress, a relatively low level of p53 is sufficient
to upregulate several antioxidant genes that decrease ROS
levels and protect cells from DNA damage (Sablina et al.,
2005).
Decreasing intracellular levels of ROS has long been a goal
for cancer prevention. Owing to the effects of many cancer
therapeutics, cancerous cells can be subjected to oxidative
stress (Renschler, 2004), increasing the understanding of how
ROS homeostasis is achieved in cancer cells, which may be
crucial for the development of more effective cancer therapies.
Cervical cancer is the second most common cancer among
women in the world in both incidence and mortality, and high-
risk human papillomavirus (HPV) – mainly serotypes 16 and
18 – is present in more than 90% of such tumors (Lazo, 1999;
zur Hausen, 1996). Most HPV-positive cervical carcinoma
cells possess the wild-type p53 gene, but it is often rendered
non-functional by the E6 oncoprotein, which complexes with
cellular proteins E6-AP and p53 to facilitate p53 degradation
via a ubiquitin-dependent proteolytic system (Scheffner, 1998).
When studied in cervical carcinoma cells expressing E6 in the
context of its natural promoter, endogenous p53 protein could
exert transcriptional function following DNA damage, despite
coexpression of the viral E6 protein, suggesting that the
amount of expressed HPV E6 is proportionate to the inhibition
of p53 activity. Basal p53 activity, as measured with luciferase
reporter assays in HPV-positive cervical cancer cells, showed
that these cells have residual p53 activity and that p53 is not
completely inactivated in cervical cancer cells (Butz et al.,
1995; Butz et al., 1999; Hietanen et al., 2000).
To provide new insight into the possible role of endogenous
p53 in the antioxidant defense of HPV-positive cervical cancer
cells, we used a plasmid-mediated short hairpin RNA (shRNA)
to knock down p53 expression in SiHa, HeLa, CaSki and
ME180 cells (all of which integrated with high risk HPV
sequences) and investigated whether p53 could modulate
intracellular ROS levels under both nonstressed and stressed
conditions. We found that endogenous p53 in SiHa cells was
involved in the modulation of ROS levels, and may participate
in maintaining ROS homeostasis. These findings might help to
facilitate future clinical studies of HPV-positive cervical cancer
therapy.
Results
Analysis of p53 and antioxidant enzymes in several
cervical carcinoma cell lines
Levels of p53 protein were examined in several cervical
carcinoma cell lines and in HFKs by immunoblot analysis with
the mouse monoclonal antibody DO1 to human p53. HFK cells
were included in this analysis as a negative control because
they do not carry HPV and the p53 level in HFKs is low, as it
is in most primary cells. SiHa cells, which contain only one
copy of HPV 16 per cell, exhibited higher amounts of p53 than
CaSki cells containing 600 copies of HPV 16, HeLa cells with
25 copies of HPV 18, and ME180 cells with HPV 68. C33A
cells, which contain mutant p53 and no HPV, also served as a
negative control in this analysis. The p53 level detected in the
C33A cell line was extremely high (Fig. 1A). Further, we
investigated the expression of p53-regulated antioxidant
enzymes GPX1, SESN1 and SESN2, and found very high
levels of GPX1 protein, SESN2 protein and SESN1 mRNA in
SiHa cells, compared with the three other HPV-positive cell
lines examined (Fig. 1A,B). Because a suitable anti-SESN1
antibody for quantification of SESN1 protein level is not
available, no western blot analysis could be done for the
SESN1 protein expression. We also tested the expressions of
SOD1 and SOD2, the similar level of each protein were found
in these six cell lines studied.
Sensitivity of cervical carcinoma cells to H2O2 challenge
Having shown the status of p53 and its regulated antioxidant
enzymes in HPV-positive cervical carcinoma cell lines, we next
analyzed the sensitivity of these cells to H2O2-induced
oxidative damage. As shown in Fig. 2, we observed differences
in the response to the H2O2 challenge in the four HPV-positive
cell lines. The SiHa cell line was the most resistant to H2O2
whereas the other three cell lines displayed similarly reduced
survival. The sublethal doses of H2O2 to SiHa, HeLa, CaSki
and ME180 were 0.8 mM, 0.2 mM, 0.2 mM and 0.1 mM,
respectively. We also found that HFK and C33A cells exerted
a similar resistance to H2O2 challenge, the sublethal dose of
H2O2 to HFK and C33A was 0.4 mM.
Downregulation of p53 elevates intracellular ROS in
SiHa cells
As SiHa cells had a higher expression of p53 and were much
more resistant to H2O2 challenge than other HPV-positive cell
lines, we attempted to analyse the impact of p53 RNAi on
intracellular ROS. We used the human U6 promoter to drive
the expression of shRNA targeting p53 in a plasmid-based
system (pSuppressorNeo p53 plasmid). A negative control
plasmid, which contained a scrambled sequence, was also
included in experiments. Each construct produced a shRNA
composed of two 19-nucleotide repeats in an inverted
orientation as shown in Fig. 3A.
When the pSuppressorNeo p53 plasmid and negative control
plasmid were transfected into SiHa cells, the p53 protein level
Fig. 1. Expression of p53 and antioxidant enzymes in human cervical
carcinoma cell lines and in HFKs. (A) Western blot analysis for p53,
GPX1, SESN2 (Hi95), SOD2 and SOD1. GAPDH was used as a
loading control. (B) RT-PCR for SESN1 and ACTB (-actin).
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was markedly decreased after 24-72 hours, compared with the
normal level of expression of p53 in the control SiHa
transfection (Fig. 3B). In contrast to p53, GAPDH was not
affected with either construct, indicating that the reduction of
p53 by applying U6-driven shRNA constructs was specific. We
further tested how p53 deficiency affects the levels of p53-
regulated antioxidant enzymes. Inhibition of p53 in SiHa cells
24-72 hours after transfection resulted in a notable decrease in
the p53-inducible transcript T2 (Woo et al., 2003) of SESN1
and a virtual disappearance of GPX1 and SESN2, whereas
there were no differences in SOD1 and SOD2 expression after
p53 knockdown in SiHa cells (Fig. 3B).
To show the effects of p53 on ROS levels in nonstressed
cells, SiHa cells were labeled with the cell-permeable
fluorescent dye CM-H2DCFDA, the fluorescence of which
Journal of Cell Science 120 (13)
increases following oxidation by H2O2 and hydroxyl radicals
in the cells. Fluorescent signals were analyzed by flow
cytometry. CM-H2DCF staining indicated that there was an
approximately twofold increase in ROS levels 24 hours after
inhibition of p53, and the high levels of ROS remained for 72
hours (Fig. 4A,B), in agreement with the above observations
that the expressions of GPX1, SESN1 and SESN2 were
markedly decreased after p53 inhibition by siRNA. Next, we
examined whether N-acetyl cysteine (NAC, a potent
antioxidant) inhibits ROS accumulation in SiHa cells. As
shown in Fig. 4C, the increase in ROS induced by p53-specific
siRNA 48 hours after transfection was almost completely
reversed by incubation with 5 mM NAC. To test whether p53
levels affect superoxide levels in SiHa cells, we employed DHE
as a cytosolic superoxide indicator and MitoSOX RED as a
Fig. 2. Cell viability of HFK,
SiHa, CaSki, HeLa, ME180
and C33A cells after H2O2
treatment as detected by
Trypan Blue assay. The data
represent the means of pooled
results from five independent
experiments.
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mitochondrial superoxide indicator. Fluorescent intensities of
both DHE and MitoSOX RED were not changed before and
after p53 knockdown in SiHa cells (Fig. 4D,E), which was
consistent with the observations that the expression of SOD1
and SOD2 were not affected by p53 deficiency in SiHa cells.
When tested in cell culture, there was no notable change in the
growth rate (Fig. 5A) or cell cycle distribution (Fig. 5B) of
SiHa cells with inhibited p53, and addition of NAC (5 mM)
did not affect cell proliferation. We also found the expression
of p53-specific siRNA did not increase ROS levels in HeLa,
CaSki and ME180 cell lines, similar to results with the negative
control plasmid (Fig. 6).
p53 deficiency promotes intracellular ROS level in SiHa
cells under oxidative stress
The results presented above suggest that p53 in the SiHa cell
line may provide a protective function by participating in
antioxidant defense. To test the role of p53 in antioxidant
defense according to the severity of oxidative stress, we
compared ROS levels in control and p53-deficient SiHa cells
stimulated with different concentrations of H2O2. 48 hours
after transfection with either the negative control plasmid
(SiHa/N) or p53 shRNA plasmid (SiHa/sip53), cells were
mock treated or treated with different concentrations of H2O2
for 12 hours and intracellular levels of ROS were analyzed.
Compared with SiHa/N cells with negative siRNA, both
untreated and H2O2-treated SiHa/sip53 cells (in which p53 was
inhibited by siRNA) exhibited markedly increased ROS levels.
Intriguingly, we also observed that even at a lethal dose of
H2O2 (1 mM), ROS level in SiHa/sip53 cells was much higher
than that in SiHa/N cells (Fig. 7). Taken together, the data
strongly suggest that endogenous p53 in HPV-positive SiHa
cells functions as an antioxidant and may play an important
role following oxidative stress.
Inhibition of p53 sensitizes SiHa cells to H2O2-induced
oxidative damage
Since the reduction of p53 induced a marked increase in the
level of ROS under both unstressed conditions and oxidative
challenge, we investigated whether p53 deficiency could
sensitize SiHa cells to oxidative damage. To address this
question, we transfected SiHa cells with a negative control
plasmid (SiHa/N) or p53 shRNA plasmid (SiHa/sip53). After
48 hours, cells were treated with varying concentrations of
H2O2 for either 12 hours or 24 hours. As expected, the
proliferation in SiHa/sip53 cells by 0.5 mM H2O2 was reduced
to 57.5% and 56.5%, 12 and 24 hours after treatment,
respectively, compared with control SiHa/N cells. Likewise,
treatment of control SiHa/N cells with 0.5 mM H2O2 had
almost no effect on cell viability. When tested at a lethal dose
of H2O2 (1 mM) for 12 and 24 hours, we found that SiHa/sip53
cells were more susceptible to H2O2-induced damage. For
example, treatment with 1 mM H2O2 for 12 hours induced
death in 68% of SiHa/sip53 cells, whereas the rate was much
lower (27%) in SiHa/N cells (Fig. 8A).
Although the XTT assay is a convenient method to measure
cell death, it does not discriminate between apoptosis and
necrosis. To determine whether apoptosis was involved in
H2O2-induced cell death, SiHa/sip53 cells were further
examined by annexin V and propidium iodide staining. Under
defined salt and Ca2+ concentrations, annexin V is predisposed
towards binding externalized phosphatidylserine (PS) that is
present on the cell surface during the early stages of apoptosis.
Addition of PI helps to distinguish between early apoptotic
cells and late apoptotic or necrotic cells because PI cannot
enter the cells in the early stages of apoptosis when the
membrane integrity is intact. Cells were treated with H2O2 for
12 hours, and apoptosis studies indicated that there was a
strong induction in early stage apoptosis (annexin V positive)
as well as in late apoptosis (annexin V and PI positive) in
SiHa/sip53 cells, as depicted in Fig. 8B. Collectively, the data
suggest that the reduction of p53 sensitized SiHa cells to
oxidative damage.
p53 deficiency increases DNA oxidation in SiHa cells
To determine whether p53 is required for the protection of
DNA from oxidative damage, we monitored the rate of
formation of 8-oxoguanine (8-oxo-dG), the major product of
DNA oxidation, using an assay kit as described in the Materials
and Methods. SiHa cells with siRNA-inhibited p53 displayed
a twofold increase in levels of 8-oxo-dG compared with control
cells (Fig. 9A). We also examined whether p53 is associated
with oxidative DNA damage induced by challenge with H2O2,
Fig. 3. Reduction of p53 levels in SiHa cells transfected with p53
siRNA or nonspecific siRNA. (A) Schematic illustration of the U6
promoter-driven shRNA constructs containing the sequence targeting
p53 and the scrambled sequence. (B) Upper panel: Expression levels
of p53, GPX1, SESN2, SOD2 and SOD1 in control or in si-p53-
expressing cells, as detected by western blot analysis. GAPDH was
used as a loading control. Middle panel: Expression of SESN1 (T2)
and ACTB as detected by RT-PCR. Lower panel: Quantification of
p53 in western blots above normalized to GAPDH expression.
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and evaluated the possible role of p53 in the removal of such
DNA damage in SiHa cells. Treatment of cells with 0.1 and
0.5 mM H2O2 for 1 hour resulted in an increase in 8-oxo-dG
levels, as indicated by the increase in fluorescence of the 8-
oxo-dG signal. However, there was a significant difference in
the levels of 8-oxo-dG in SiHa/N and SiHa/sip53 cells.
SiHa/sip53 cells consistently exhibited higher 8-oxo-dG
content than SiHa/N cells (Fig. 9B). Therefore, these data
Journal of Cell Science 120 (13)
suggest that in the SiHa cell line, p53 may participate in
protecting DNA from oxidative damage.
p53 facilitates the removal of 8-oxo-dG residues from
DNA in whole SiHa cells
Finally, we performed pulse-chase experiments to test whether
p53 facilitates the removal of 8-oxoG residues from DNA in
the SiHa cell line. 48 hours after transfection with negative
Fig. 4. Effect of deficiency in p53 on
intracellular ROS level in the SiHa cell
line. (A) Intracellular ROS levels in
SiHa cells measured by CM-
H2DCFDA staining and FACS analysis
at different time intervals after
transfection with p53 siRNA or
nonspecific siRNA. (B) ROS levels
expressed as the mean ± s.d. intensity
of cell fluorescence. *P<0.001
compared with the corresponding
negative control by Student’s t-test.
(C) FACS analysis of CM-H2DCFCA-
stained cells treated with NAC (5 mM,
6 hours) 48 hours after transfection
with p53 siRNA or nonspecific siRNA.
*P<0.01 compared with the
corresponding untreated group by
Student’s t-test. (D) Cytosolic
superoxide levels in SiHa cells
transfected with p53 siRNA or
nonspecific siRNA measured by DHE
staining and FACS analysis.
(E) Mitochondrial superoxide levels in
SiHa cells transfected with p53 siRNA
or nonspecific siRNA measured by
MitoSOX RED staining and FACS-
analysis.
Fig. 5. Characterization of SiHa cells with inhibited expression of p53. (A) Growth curves of SiHa/N and SiHa/sip53 cells untreated or treated
with 5 mM NAC. *P>0.98 by Student’s t-test. (B) Cell cycle distribution of SiHa/N and SiHa/sip53 was analyzed 48 hours after transfection.
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control plasmid or p53 shRNA plasmid, cells were treated
with 0.5 mM H2O2 for 1 hour to induce 8-oxo-dG
accumulation. After treatment, the medium was changed and
the cells were incubated without H2O2 for various times. To
evaluate the rate of 8-oxo-dG elimination, the level of 8-oxo-
dG remaining was detected at each time point. SiHa/sip53
cells were slower than SiHa/N cells to remove 8-oxo-dG from
the DNA, with the time for the level of 8-oxo-dG to decrease
by 50% (t1/2) was 3.1 hours and more than 6 hours,
respectively (Fig. 10).
Discussion
Persistent infection by high-risk types of HPV has been
associated with the development of human cervical cancer.
Based on epidemiological and experimental evidence, it is
widely accepted that carcinogenesis of HPV-infected cells is a
process involving integration of the viral genome in cancer
cells, resulting in the loss of expression of the viral E2 gene
and the persistence of E6 and E7 oncoprotein expression (Jeon
et al., 1995). The oncogenic activity of high-risk HPVs is
explained in part by the ability of the viral E6 oncoprotein to
Fig. 6. ROS levels in HeLa
(A), CaSki (B) and ME180
(C) cells 48 hours after
inhibition of p53 with siRNA
(sip53). For a negative
control we used nonspecific
siRNA. *P>0.95 compared
with the corresponding cells
with negative control vector
(Student’s t-test). (D)
Expression levels of p53
mRNA in both control and
si-p53-expressing cells 48
hours after transfection with
corresponding plasmid, as
detected by RT-PCR.
Fig. 7. Effect of p53 deficiency on intracellular
ROS level in SiHa cells undergoing oxidative
stress. (A) ROS levels in untreated and H2O2-
treated (12 hours) SiHa and SiHa cells with p53
inhibited with siRNA, as detected by FACS
after CM-H2DCFCA-staining. (B) ROS levels
were expressed as the mean ± s.d. intensity of
cell fluorescence. *P<0.001 compared to the
corresponding negative control by Student’s
t-test.
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target p53 for degradation and thus to inhibit p53-mediated
transcription (Hoppe-Seyler and Butz, 1993). However, studies
investigating the functional status of p53 in a series of HPV-
positive cancer cells expressing the E6 gene from
chromosomally integrated viral sequences under its natural
promoter have produced differing results, indicating that
despite co-expression of the viral E6 oncogene, there is
residual p53 activity, indicating that endogenous p53 is not
completely inactivated in HPV-positive cancer cells
(Abdulkarim et al., 2002; Butz et al., 1995; Butz et al., 1999;
Hengstermann et al., 2001; Hietanen et al., 2000). To date,
there are no suitable anti-E6 antibodies available for reliable
quantification, and thus the presence of viral E6 protein has not
been unambiguously demonstrated in HPV-positive cancers.
Therefore, it is currently widely assumed that E6 protein levels
are very low in HPV-positive carcinoma cell lines and might
be limited in their capacity to interfere with p53 function. In
the present study, we found that endogenous p53 in SiHa cells
is involved in the modulation of intracellular ROS levels,
participates in maintaining ROS homeostasis in response to
oxidative stress and protects DNA against oxidative damage.
Journal of Cell Science 120 (13)
Direct comparison of p53 protein levels between HPV-
positive cervical carcinoma cell lines, as examined by
immunoblot analysis, indicated that SiHa cells had the highest
steady-state level of p53. This result is in full agreement with
previous findings Scheffner et al. (Scheffner et al., 1991) who
showed that p53 level in SiHa cells is 3-5 times higher than
that in other HPV-positive cervical cancer cells. A recent study
(Sablina et al., 2005) provided evidence that even the very low
levels of p53 present in normal tissues in the absence of stress
are sufficient enough to drive the expression of several
antioxidant genes. Therefore, we next addressed the hypothesis
that high levels of p53 in SiHa cells may contribute to some
antioxidant enzymes. Indeed, among the series of HPV-positive
cancer cell lines investigated in this study, SiHa cells exhibited
the highest expression of GPX1, SESN1 and SESN2, implying
that SiHa cells may have a powerful antioxidant defense
system and are thus tolerant of severe oxidative insults. By
using H2O2 to induce oxidative stress, we found that HeLa,
CaSki and ME180 cells were severely impaired in their
antioxidant capacity, whereas SiHa cells, as expected,
exhibited a higher resistance to H2O2 damage. Given the
Fig. 8. Inhibition of p53-sensitized SiHa cells to H2O2-induced oxidative damage. (A) 48 hours after transfection with negative control plasmid
(SiHa/N) or p53 shRNA plasmid (SiHa/sip53), cells were treated with various concentrations of H2O2 for either 12 hours or 24 hours, after
which time cell viability was measured with an XTT assay. Results shown are expressed as mean ± s.d. of triplicate microcultures. *P<0.01
compared with the corresponding negative control using Student’s t-test. (B) Apoptosis and death levels of SiHa/N and SiHa/sip53 cells 12
hours after treatment with 0.1, 0.5 and 1 mM of H2O2 as detected by FACS after Annexin V/PI staining. Apoptotic (Annexin V+/PI–), dead
(Annexin V+/PI+) and alive (Annexin V–/PI–) populations were readily identified. The rates of apoptotis and death are shown in upper right and
lower right panels, respectively. *P<0.01 compared with the corresponding untreated cells (Student’s t-test).
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evidence that p53 is a major regulator of the H2O2 response in
human cells (Desaint et al., 2004), the above findings raised
the question whether the presence of a high steady-state level
of p53 in SiHa cells has an antioxidant function.
Expression of p53 was knocked down by transfecting U6
promoter-driven shRNA constructs into SiHa cells. We were
able to demonstrate that p53 was reduced 24-72 hours post
transfection, compared with that in the control. Likewise, the
levels of GAPDH protein and ACTB (encoded -actin) mRNA
remained unchanged, indicating that the reduction of p53 was
specific. Interestingly, we also noted that the expression of
GPX1, SESN1 and SESN2 were also inhibited following p53
RNAi in SiHa cells. These observations further supported the
idea that p53 is transcriptionally competent despite co-
expression of the viral E6 protein and could induce antioxidant
gene expressions in SiHa cells in the absence of stress.
Elevated levels of ROS were also found in p53-deficient SiHa
cells, although this could be reversed by NAC supplementation.
These data strengthened the idea that the antioxidant function
of p53 is mediated through a set of antioxidant gene products,
and the depletion/downregulation of p53 damped down the
antioxidant defense in SiHa cells.
Intriguingly, although p53 deficieny promoted ROS levels in
SiHa cells, we did not observe a similar correlation between
p53 protein and ROS levels in the other three HPV-positive
cervical cancer cells HeLa, CaSki and ME180. Different
scenarios could be envisaged to explain the differences in the
modulation of ROS by p53 in the HPV-positive cancer cells
investigated in the present study. The transcriptional activity of
p53 to activate antioxidant genes is necessarily correlated with
p53 protein abundance, and a steady-state level of p53 may be
required for its transcriptional activity in HPV-positive cells
under physiological conditions. Consistent with this notion, the
p53 levels in HeLa, CaSki and ME180 cells were much lower
than that in normal HFK cells. It has been reported that p53
levels detected in HeLa, CaSki and ME180 cells ranged from
0.4- to 0.6-times that found in secondary cultures of HFKs
(Scheffner et al., 1991). Furthermore, the levels of p53-
regulated antioxidant enzymes, GPX1, SESN1 and SESN2,
were very low, and even undetectable in the three cell lines. In
addition, there may also be cell-specific differences in the
regulation of cellular antioxidant abilities between these cell
lines. It will also be interesting to study the role of HPV in the
differential response of these HPV-positive cell lines to
oxidative stress because these cell lines harbor different
subtypes and copies of HPV.
In concordance with the notion that the p53 protein is
functional in SiHa cells, we observed a much higher level of
ROS in p53-deficient SiHa cells following H2O2 exposure than
in SiHa cells containing wild-type p53. Indeed, it has been
shown previously that p53 induces ROS accumulation and a
number of genes induced by p53 are associated with the
metabolism of ROS (Macip et al., 2003; Polyak et al., 1997).
Understanding how p53 stimulates the accumulation of ROS
level is complicated by the opposite finding that p53 also
regulates the expression of antioxidant enzymes. The study
from by Sablina et al. extended such observations that (1) in
the absence of stress or after mild stress, p53 induces the
expression of antioxidant genes that decrease ROS levels and
protect cells from DNA damage; (2) severe or extended stress
leads to stronger activation of p53, and thus induces the pro-
oxidant genes, results in elevated ROS levels and cell death
(Sablina et al., 2005; Bensaad and Vousden, 2005). In the
present study, the p53-deficient cells showed a higher ROS
level than control cells did, even at lethal concentrations of
H2O2 (1 mM). These findings were in contrast with a previous
study (Sablina et al., 2005) in which p53 showed pro-oxidant
activity and thus promoted ROS levels in HPV-negative cell
types under severe oxidative damage. One possible explanation
may be that the antioxidant and pro-oxidant function of p53
was temporally separated (Bensaad and Vousden, 2005;
Sengupta and Harris, 2005) and the pro-oxidant function of
p53 is severely impaired in SiHa cells.
Furthermore, cells containing reduced p53 were more
susceptible to H2O2-induced cell death. As shown in this study,
a more rapid and greater magnitude of cell death was observed
in SiHa cells with p53 deficiency after H2O2-challenge,
indicating that the antioxidant defense of the SiHa cell line was
achieved, at least in part, by endogenous p53, and therefore
depletion of p53 followed by inhibition of the expression of
some antioxidant enzymes disintegrated the antioxidant
firewall and sensitized cells to oxidative stress.
The p53 tumor suppressor, a ‘guardian of the genome’,
restricts abnormal or stress-exposed cells before DNA damage
becomes fixed as a mutation (Lane, 1992). A key target of ROS
Fig. 9. Reduction of p53 expression increased DNA oxidation in
SiHa cells. (A) 8-oxo-dG level in SiHa cells expressing negative
control plasmid (SiHa/N) or p53 shRNA plasmid (SiHa/sip53) 48
hours after transfection. (B) 48 hours after transfection with negative
control plasmid or p53 shRNA plasmid, cells were treated with the
indicated concentrations of H2O2 for 1 hour. Quantification of 8-oxo-
dG staining was performed after FACScan analysis using CellQuest
software. 8-oxo-dG levels are expressed as the mean ± s.d. intensity
of cell fluorescence. *P<0.01 compared with the corresponding cells
with negative control vector by Student’s t-test.
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in cells is the DNA, and under physiological conditions the
endogenous ROS that are byproducts of normal respiration
modify approximately 20,000 bases of DNA per day in a single
cell (Beckman and Ames, 1997; Droge, 2002; Finkel, 2003).
Thus, endogenous ROS are a major source of DNA damage
and a substantial factor contributing to chromosomal
instability, accumulation of mutations (Jackson and Loeb,
2001; Klungland et al., 1999) and deletions that may lead to
cancer (Griffiths et al., 1997; Havre et al., 1995). A frequent
oxidative modification of DNA is the hydroxylation of guanine
at C-8, leading to the formation of 8-oxo-dG) (Breen and
Murphy, 1995; Wiseman and Halliwell, 1996). In the present
study, we showed that p53 protein in the SiHa cell line has a
protective role against DNA oxidation. SiHa cells deficient in
p53 displayed significantly increased 8-oxo-dG levels under
both non-stressed and oxidative stressed conditions, a finding
that was consistent with the observation that 8-oxo-dG residues
were removed more rapidly from cellular DNA in whole SiHa
cells with wild-type p53. Together, these results suggested that
the endogenous p53 in the SiHa cell line plays a role in
Journal of Cell Science 120 (13)
protecting DNA and facilitating cellular
responses to ROS-induced DNA damage.
In conclusion, we have provided evidence
that endogenous p53 in SiHa cells has an
antioxidant function and is involved in the
reinforcement of the antioxidant defense.
Depletion of p53 by RNAi in the SiHa cell line
resulted in disintegration of the antioxidant
firewall and increased oxidative damage. As
ROS are also involved in cancer
chemoradiotherapy, these findings may help
to facilitate clinical studies of HPV-positive
cervical cancer therapy.
Materials and Methods
Cell lines and cell culture
Five cervical carcinoma cell lines, SiHa, CaSki, HeLa,
ME180 and C33A, were used in this study. SiHa and CaSki
contain integrated HPV 16; HeLa cells carry integrated HPV
18; and ME180 cells contain HPV 68 sequences; C33A cells
are HPV-negative, and contain mutant p53. SiHa, HeLa and
C33A cells were grown in DMEM (Gibco-BRL, Grand
Island, NY), CaSki and ME180 cells were maintained in
RPMI 1640 medium (Gibco), supplemented with 10% fetal
bovine serum (FBS), 100 U/ml penicillin, and 100 g/ml
streptomycin. Normal human foreskin keratinocytes (HFKs)
were obtained from Cambrex Bio Science (Walkersville,
USA) and grown in KGM Bulletkit (Cambrex). Cultures were
maintained at 37°C in a 5% CO2 atmosphere at 100%
humidity.
Western blot analysis
Cell lysates were made using the PRO-PREP protein
extraction solution (Intron Biotech, Korea). Lysates were
clarified by centrifugation at 15,000 g at 4°C for 20 minutes
and the protein concentration of the supernatant was
determined with a Bradford assay (BioRad). For SDS-PAGE
protein lysates were mixed with Laemmli sample buffer and
boiled for 20 minutes. Total protein was separated on a 12%
gel and transferred to nitrocellulose (Amersham, Germany).
After blocking in TBST (20 mM Tris-HCl, 137 mM NaCl,
0.1% Tween 20, pH 7.6) with 5% skimmed milk, membranes
were incubated with the primary antibodies diluted in TBST
with 3% skimmed milk for 2 hours at room temperature.
Next, membranes were washed three times with TBST, and
incubated for an additional 2 hours with horseradish
peroxidase-linked secondary antibody (1:2000) diluted in
TBST with 3% skimmed milk. Labeled protein bands were
visualized with the enhanced chemiluminescence reagent
(ECL) (Pierce, Rockford). Mouse monoclonal DO1 antibody against p53 (1:2000),
goat polyclonal antibody against SOD2 (1:200), rabbit polyclonal antibody against
SOD1 (1:200) and goat polyclonal antibody against GAPDH (1:2000) were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse monoclonal
antibody against GPX1 (2 g/ml) was obtained from MBL (Japan). Rabbit
polyclonal antibody against SESN2 (1:1000) was purchased from Proteintech
(Chicago, IL). Horseradish peroxidase-labeled secondary antibodies were
purchased from Zymed. Immunoblotting for GAPDH was performed to verify
equivalent protein loading. Densitometry analysis of western blots was performed
using TINA 2.0 Software (Raytest Isotopenmessgerate Gmbh, Straubenhardt,
Germany).
RNA isolation and RT-PCR analysis
Cells were collected and total RNA was extracted using an UltraspecTM-II RNA
isolation kit (Biotecx, Houston, TX). To prepare cDNA, 500 ng total RNA was
mixed with the SuperScript RT-PCR System (Invitrogen). 5 l of the RT reaction
was then used for PCR using the HotStarTaq DNA polymerase (Qiagen). The PCR
reactions were carried out under the following temperature profile: (1) denaturation
at 95°C for 15 minutes; (2) 35 cycles of 95°C for 40 seconds, 56°C for 1 minute,
72°C for 1 minute; (3) a final extension for 10 minutes at 72°C. To detect the
corresponding gene expression, we used the following primers: TP53, 5-TCC -
ACTACAACTACATGTGTAAC-3 and 5-GTGAAATATTCTCCATCCAGTG-3;
SESN1 (T2), 5-CGACCAGGACGAGGAACTT-3 and 5-CCAATGTAGTGAC -
GATAATGTAGG-3 ACTB, 5-AAGAGAGGCATCCTCACCCT-3 and 5-TAC -
ATGGCTGGGGTGTTGAA-3.
Fig. 10. p53 facilitated the removal of 8-oxo-dG residues from DNA in whole SiHa
cells. (A) 48 hours after transfection with negative control plasmid (SiHa/N) or p53
shRNA plasmid (SiHa/sip53), cells were treated with 0.5 mM H2O2 for 1 hour. The
cells were washed with fresh medium and then incubated in fresh medium for the
indicated times. 8-oxo-dG levels were measured at each time point as indicated and
expressed as fold of the control sample. (B) The percentage of remaining 8-oxo-dG
residues in cellular DNA was plotted as a function of chase time. The t1/2 value
reflects the estimated time for levels of 8-oxo-dG to decrease to 50% of its original
level.
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RNA interference
To generate a short hairpin RNA specific for p53, we used the pSuppressorNeo p53
plasmid (IMG-803, Imgenex, San Diego, CA). A negative control plasmid (IMG-
800) with a scrambled sequence was supplied by Imegenex. The following
sequences, representing 19 bp of the mRNAs, were present in the hairpin transcripts:
TP53, 5-GACTCCAGTGGTAATCTAC-3; negative control, 5-AGTCACGT -
TAATGGTCGTT-3. Cells were cultured overnight and transfected with
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the protocol of the
manufacturer. Briefly, both the DNA and Lipofectamine 2000 were diluted with
serum-free medium. The diluted DNA was added to the diluted Lipofectamine 2000,
mixed gently, and incubated at room temperature for 30 minutes. Lastly, the DNA-
Lipofectamine 2000 mixture was carefully added to cells at 95% confluency in fresh
medium without antibiotics and incubated at 37°C.
Cell proliferation and viability analysis
To measure the number of viable cells, a Trypan Blue exclusion assay was used.
Cells were seeded in a 24-well plate and incubated for 24 hours. At the indicated
time points, cells were collected and stained with 0.2% Trypan Blue. Cell numbers
were determined by direct counting of cells under the microscope, using a standard
haemocytometer. Cell viability was measured using a WelCountTM Cell Viability
Assay Kit (WelGENE, Seoul, Korea). Briefly, we defrosted the XTT reagent and
PMS at 37°C, prepared the reaction mixture (40 l PMS and 2 ml XTT reagent per
plate), added 20 l of the reaction mixture to each well (each containing 100 l
media) and incubated at 37°C for 4 hours. After observing a change in color of the
solution, we measured these samples at a wavelength of 490 nm using a Molecular
Devices VERSAmax microplate reader (Molecular Devices, Sunnyvale, CA). All
experiments were performed in triplicate.
Measurement of ROS accumulation
Intracellular production of ROS was measured using cell-permeable fluorescent
dyes, 5-(and-6)-chloromethyl-2,7-dichlorodihydrofluorescein diacetate, acetyl
ester (CM-H2DCFDA, Molecular Probes), dihydroethidium (DHE, Molecular
Probes) and MitoSOX RED (Molecular Probes). When these dyes are oxidized by
ROS in cells, their fluorescent signals increase. CM-H2DCFDA is mainly oxidized
by hydrogen peroxide (H2O2) and hydroxyl radicals, DHE is oxidized by cytosolic
superoxide anion, whereas MitoSOX RED is selectively oxidized by superoxide
anion in the mitochondria. For the assay, cells were plated in six-well plates and
loaded with CM-H2DCFDA or DHE for 30 minutes, or MitoSOX RED for 10
minutes in the dark at 37°C. Next, cells were washed twice with PBS, trypsinized
and fluorescence was measured using flow cytometry (excitation at 488 nm,
emission at 515–545 nm). Data analysis was performed with CELLQuest software
and the mean fluorescence intensity was used to quantify the responses. A minimum
of 10,000 cells was acquired for each sample.
Cell cycle distribution observation
Flow cytometry analysis of PI-stained cells was performed to demonstrate the
progression of the cell cycle. Briefly, cells were harvested, washed and fixed in 70%
ethanol overnight at 4°C. Prior to flow cytometry, cells were washed and stained
with 1 ml PI (5 g/ml) containing 0.1 mg/ml RNaseA. DNA content was determined
with a FACScan flow cytometer (Becton Dickinson) and the proportion of cells in
a particular phase of cell cycle was determined with CellQuest software.
Apoptosis assay by Annexin V/PI staining
An Annexin V-FITC Apoptosis Kit I (BD, San Jose, CA, USA) was used to detect
apoptosis. Annexin V is a Ca2+-dependent phospholipid-binding protein that has a
high affinity for phosphatidylserine (PS). In apoptotic cells, PS is translocated from
the inner leaflet of the plasma membrane to the outer leaflet. Propidium iodide (PI),
a standard flow cytometric viability probe, was used to distinguish between viable
and nonviable cells. Cells that were stained were detected by a flow cytometer.
Briefly, 1106 cells were harvested, washed with ice-cold PBS, and resuspended
in 500 l of Annexin binding buffer. A 100 l aliquot (2105 cells) was taken, 5
l each of Annexin V-FITC and PI were added and cells were incubated for 15
minutes at room temperature in the dark. 400 l binding buffer (10 mM HEPES-
NaOH pH 7.4, 140 mM NaCl, 2.5 mM CaCl2) was added and samples were acquired
on a FACScan flow cytometer (FACSCalibur, Becton Dickinson) and analyzed using
CELLQuest software with in 1 hour. Cells that were Annexin V–/PI+ were counted
as necrotic, those that showed up as Annexin V+/PI+ were counted as late apoptotic
or secondarily necrotic, and Annexin V+/PI– cells were recognized as apoptotic. All
procedures stated above were performed according to the manufacturer’s
instructions.
Detection of 8-oxo-dG residues in DNA
After transfection with the pSuppressorNeo p53 or negative control plasmids for 48
hours, cells were treated with H2O2 at concentrations of 0.1 mM and 0.5 mM for 1
hour. The levels of 8-oxo-dG residues in cellular DNA before and following
treatment with H2O2 were determined using the OxyDNA assay kit (EMD
Biosciences, San Diego, CA). This assay is based upon the direct binding of a
fluorescent probe to 8-oxoguanine in the DNA of fixed cells (Achanta and Huang,
2004; Struthers et al., 1998). Cells were harvested, washed with PBS, and fixed with
2% paraformaldehyde on ice for 15 minutes. The samples then were washed with
PBS and fixed in 70% ethanol at –20°C overnight. The following day, the cells were
washed once with PBS, followed by the wash solution provided by the manufacturer.
Next, the cells were incubated with blocking solution, and then treated with the 8-
oxo-dG-specific FITC-labeled probe and analyzed by flow cytometry according to
the manufacturer’s protocol. The intensity of the FITC fluorescent signal was
proportional to the level of 8-oxoG residues in DNA.
Analysis of 8-oxo-dG residue removal from DNA
A pulse-chase experiment was used to assay the removal of 8-oxo-dG residues from
DNA in whole cells. First, cells were transfected with pSuppressorNeo p53 or
negative control plasmids for 48 hours. Following the transfection, cells were treated
with 0.5 mM H2O2 for 1 hour. Afterwards, cells were rinsed with fresh medium
(without H2O2) incubated. Cells were harvested before or at various times after
incubation in fresh medium. Relative abundance of 8-oxo-dG in cellular DNA was
measured as described previously. The decrease of 8-oxoG signal as a function of
the chase time was taken as 8-oxoG removal from DNA in whole cells.
Statistical analysis
The Student’s t-test was used for statistical analysis. Statistical significance was
accepted if the null hypothesis was rejected with P<0.05.
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